Pulpotec® is indicated for: ADULTS: Treatment of pulpitis on permanent vital molars; Treatment of molars suffering calcified root canal (for gerodontics). PEDODONTICS: Treatment of pulpitis in primary vital molars; Treatment of pulpitis on immature permanent vital molars, enabling a complete radicular development of the tooth. Treatment of infected primary molars even in the presence of an abscess. Efficiency - How Pulpotec® guarantees aseptic treatment Antiseptics effect of pulpotomy materials is key because tissue repair only occurs in the absence of an infectious process. Pharmacological constituents of Pulpotec® are important to understand the high clinical and radiographical success rate associated with this product. The pharmacological constituents are iodoform, polyoxymethylene, phenol, formaldehyde, guaiacol, and dexamethasone acetate. It leads to a paste with the following main properties: Antiseptics – antiviral, germicidal, sporicidal, antibacterial, antimicrobial; Anti-inflammatory; Local anaesthetic. The antiseptics and anti-inflammatory constituents of Pulpotec® are broad spectrum. For example, formaldehyde is a relatively non-specific bactericidal agent, meaning it affects the growth and viability of most gram-positive and gram-negative bacteria as well as fungi. However, one of the main advantages of Pulpotec® is the synergetic action of the different constituents, making the product efficient against critical bacteria, including E.faecalis, E. coli or S. aureus. Thanks to these constituents and their related actions, Pulpotec® allows an aseptic treatment, prevents contamination of the pulpal chamber by microorganisms and induces cicatrisation of the pulpal stump at the chamber/canal interface. But most importantly, it maintains the structure and vitality of the underlying pulp.